Izotropic(OTC) IZOZF

Current Price$0.19

Market Cap$12.89M

Since IPO (2019)-32%

5 Year-68%

1 Year-1%

1 Month+6%

Izotropic last closing stock price
Metric	Price	Date
Last close	USD 0.19	2026-07-22

Izotropic stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+3.78%	USD 0.18	2026-07-15
1 month	+5.6%	USD 0.18	2026-06-22
3 month	-7.52%	USD 0.20	2026-04-23
Year to date	-7.98%	USD 0.20	2025-12-31
1 year	-0.85%	USD 0.19	2025-07-22
3 year	+6.14%	USD 0.18	2023-07-21
5 year	-68.4%	USD 0.59	2021-07-23
Since inception	-32.07%	USD 0.28	2019-03-12

Izotropic Financials at a Glance

Market Cap

$12.89M

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$2.52M

EPS (TTM)

-$0.03

P/E Ratio

-6.60

Dividend

$0.00

Beta (Volatility)

0.22 (Low)

Dividend

$0.00

Beta (Volatility)

0.22 (Low)

Price

$0.19

Volume

4,220

Open

$0.18

Price

$0.19

Volume

4,220

Open

$0.18

Previous Close

$0.19

Daily Range

$0.18 - $0.19

52-Week Range

$0.12 - $0.37

Estimated Earnings Date

Mar 30, 2026

Dividend

$0.00

Beta (Volatility)

0.22 (Low)

Price

$0.19

Volume

4,220

Open

$0.18

Previous Close

$0.19

Daily Range

$0.18 - $0.19

52-Week Range

$0.12 - $0.37

Estimated Earnings Date

Mar 30, 2026

IZOZF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Izotropic

Izotropic Corporation is a medical technology company dedicated to advancing diagnostic solutions for breast cancer. The firm specializes in developing and selling a specialized breast CT imaging system and a 3D CT breast imaging platform, aimed at enhancing early detection and accurate diagnosis of breast cancer.

Products and Services

Specialized breast CT imaging system for enhanced diagnostics
3D CT breast imaging platform for improved detection
Research and development focused on innovative medical technologies

Growth Outlook

Market demand for advanced breast cancer diagnostics is increasing
Expansion into new markets anticipated in the coming years
Continued investment in R&D to drive product innovation

Financial Highlights

Recent quarterly net income reported at -$262,522
Trailing twelve months (TTM) revenue of $0
Cash and cash equivalents increased to $364,655 in Q3 2026

Izotropic Corporation operates in the medical diagnostics and research industry, focusing on breast cancer detection technologies. The company has positioned itself to meet the growing demand for advanced diagnostic solutions, which is critical given the rising incidence of breast cancer globally. The innovative products offered by Izotropic aim to facilitate earlier detection, potentially leading to better patient outcomes. Despite recent financial challenges, including a net income loss, the company has shown resilience with an increase in cash reserves. The focus on research and development is expected to drive future growth, as the company seeks to expand its market presence and enhance its product offerings. Investors may find interest in the potential for growth in a sector that is increasingly prioritizing advanced diagnostic technologies.

AI Generated • Jul 4, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Robert Louis Thast

Website

www.izocorp.com

Headquarters

Surrey, BC V4A 2H9, CA

IZOZF Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

48.20%

Return on Capital

N/A

Return on Assets

-368.33%

Earnings Yield

-15.15%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.89M

Shares Outstanding

68.98M

Volume

4.22K

Avg. Volume

17.31K

Financials (TTM)

Gross Profit

-CA$26.79K

Operating Income

-CA$2.49M

EBITDA

-CA$2.10M

Operating Cash Flow

-CA$900.05K

Capital Expenditure

CA$0.00

Free Cash Flow

-CA$900.05K

Cash & ST Invst.

CA$364.66K

Total Debt

CA$3.14M

Izotropic Performance Analysis

Izotropic annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-04-30	CAD 0	N/A
2023	2023-04-30	CAD 0	N/A
2024	2024-04-30	CAD 0	N/A
2025	2025-04-30	CAD 0	N/A

Izotropic sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2025-04-30	N/A
Q1	2025-07-31	N/A
Q2	2025-10-31	N/A
Q3	2026-01-31	N/A

Izotropic annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-04-30	CAD -0.12	N/A
2023	2023-04-30	CAD -0.09	-31.0%
2024	2024-04-30	CAD -0.02	-74.7%
2025	2025-04-30	CAD -0.04	78.6%

Izotropic sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2025-04-30	-101.2%
Q1	2025-07-31	71.3%
Q2	2025-10-31	-152.1%
Q3	2026-01-31	66.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

-CA$7.65K

+17.0%

Gross Margin

0.00%

N/A

Market Cap

$12.89M

N/A

Market Cap/Employee

$2.58M

N/A

Employees

N/A

Net Income

-CA$262.52K

+46.1%

EBITDA

-CA$352.84K

+14.4%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Total Cash

CA$364.66K

+65.2%

Total Debt

CA$3.14M

+54.9%

Accounts Receivable

CA$5.46K

+11.0%

Inventory

CA$0.00

N/A

Long Term Debt

CA$68.03K

+1625.4%

Short Term Debt

CA$3.07M

+51.9%

Return on Assets

-3.68%

N/A

Return on Invested Capital

47.45%

N/A

Free Cash Flow

-CA$157.47K

+24.8%

Operating Cash Flow

-CA$157.47K

+24.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AVCNFAvicanna Inc.

AVCNFAvicanna Inc.$0.10+8.60%

EMITFElbit Imaging Ltd.

EMITFElbit Imaging Ltd.$1.60+0.00%

MEDIFMediPharm Labs Corp.

MEDIFMediPharm Labs Corp.$0.06+1.79%

RAPHRaphael Pharmaceutical Inc.

RAPHRaphael Pharmaceutical Inc.$1.40+0.00%

GBLPGlobal Pharmatech, Inc.

GBLPGlobal Pharmatech, Inc.$0.08+0.00%

CWBHFCharlotte's Web Holdings, Inc.

CWBHFCharlotte's Web Holdings, Inc.$0.22-2.42%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$8.00+0.04%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.56+0.20%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.79-0.03%

NOKNokia

NOKNokia$10.28-0.03%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$115.26-0.07%

FFord Motor Company

FFord Motor Company$14.42+0.01%

TET1 Energy Inc.

TET1 Energy Inc.$6.03-0.01%

Questions About IZOZF

What is the current price of Izotropic?

Izotropic is trading at $0.19 per share.

What is the 52-week range for Izotropic?

Over the past 52 weeks, Izotropic has traded between $0.12 and $0.37.

How much debt does Izotropic have?

As of the most recent reporting period, Izotropic reported total debt of CA$2.32M.

How much cash does Izotropic have on hand?

Izotropic reported CA$268.86K in cash and cash equivalents in its most recent financial results.

What is Izotropic’s dividend yield?

Izotropic does not currently have a dividend yield.

Izotropic(OTC) IZOZF

Izotropic Financials at a Glance

IZOZF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Izotropic

IZOZF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Izotropic Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IZOZF

What is the current price of Izotropic?

What is the 52-week range for Izotropic?

How much debt does Izotropic have?

How much cash does Izotropic have on hand?

What is Izotropic’s dividend yield?

Premium Investing Services